Condition
Concentrated Growth Factors
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Not Yet Recruiting2
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07520513Not ApplicableNot Yet Recruiting
Socket Shield Technique With CGF and Xenograft for Immediate Implants
NCT07520526Not ApplicableNot Yet Recruiting
Immediate Implant Placement Using Socket Shield With CGF
NCT04698317Phase 2Completed
Beta-Tricalcium Phosphate and Concentrated Growth Factors in Treatment of Intra-bony Defect Randomized Clinical Trial
NCT03180658Not ApplicableUnknownPrimary
Concentrated Growth Factors in Regenerative Therapy in Furcation Involvements in Humans
Showing all 4 trials